First copies of gilead virus drug to start selling in Bangladesh
3770
Thursday, 21 May, 2020, 15:45
Bangladesh’s Beximco Pharmaceuticals Ltd. said it has become the world’s first company to start selling the generic version of Gilead Sciences Inc.’s antiviral drug on mounting urgency to treat the infection caused by the deadly coronavirus across the developing world. The Dhaka-based Beximco, which counts Norges Bank as one of its investors, will sell remdesivir for about 6,000 taka ($71) a vial to private clinics but will give it free to state-run hospitals treating Covid-19 patients, Rabbur Reza, chief operating officer at the company, said in an interview. A critically ill Covid-19 patient will need at least six vials, he said. |
Doctors remove live cockroach from intestine after Delhi man complains of stomach ache (photo)
200320.10.2024, 18:54The horrifying details of the “newborn gang” scandal in Türkiye have rocked the nation
195819.10.2024, 01:06'Out of darkness, can come light': Kate's message in full (video)
227309.09.2024, 22:12Over 70 factories in Ashulia shut down amid workers’ protests
206204.09.2024, 20:24First children in Gaza given polio vaccine
210101.09.2024, 00:30Mpox cases are rising in Australia’s eastern states
164716.08.2024, 10:48